Literature DB >> 16739964

Scale-up of breast cancer stem cell aggregate cultures to suspension bioreactors.

Benjamin S Youn1, Arindom Sen, Leo A Behie, Adele Girgis-Gabardo, John A Hassell.   

Abstract

It has been hypothesized that breast tumor formation results from the activity of a scarce population of cells known as Breast Cancer Stem Cells (BrCSCs) and that the development of effective breast cancer therapies may therefore ultimately rely upon the ability to effectively target these cells for eradication. The scarcity of BrCSCs in vivo severely compromises research on these populations, as analyses are restricted to those requiring small cell numbers, and has become a major impediment to the development of therapeutic strategies against breast cancer. Through the culture of murine tissue aggregates containing a population of BrCSCs, this study demonstrates the ability of propagating this scarce population in a controlled and reproducible manner, within suspension bioreactors. A rigorous theoretical framework has been developed in order to understand and characterize the implications of oxygen mass transfer within aggregates upon scale-up and thereby provide a foundation for the scale-up of aggregate cultures. A two-factor, two-level factorial experimental design was also performed in order to assess the effects of inoculation density and hydrodynamic shear upon cell yield. We discovered that the culture of the murine aggregates in a relatively low shear environment (tau(max) = 0.20 Pa) and inoculated at 3.50 x 10(4) cells/mL resulted in the best yields for the range of conditions investigated in suspension bioreactors. A detailed study on the oxygen uptake kinetics of the aggregates also revealed that the uptake rates were not significantly affected by mass transfer limitations, as uptake rates of aggregate cultures were found to be comparable to those observed in single cell cultures. Cells propagated in a process controlled 500 mL suspension bioreactor resulted in growth kinetics that were comparable to those observed in 125 mL bioreactors. Doubling times in the 500 mL vessel were found to be 23.9 h and attained a maximum cell density of 1.20 x 10(6) cells/mL. After enumerating the number of BrCSCs, this resulted in an approximately 20-fold increase in BrCSC numbers in batch suspension cultures. With greater attention being applied to BrCSCs, their propagation in suspension bioreactors makes available experimental avenues that are not currently accessible and may thereby enable the development of more effective therapeutic drugs for the treatment of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16739964     DOI: 10.1021/bp050430z

Source DB:  PubMed          Journal:  Biotechnol Prog        ISSN: 1520-6033


  17 in total

1.  Embryonic stem cell bioprinting for uniform and controlled size embryoid body formation.

Authors:  Feng Xu; Banupriya Sridharan; Shuqi Wang; Umut Atakan Gurkan; Brian Syverud; Utkan Demirci
Journal:  Biomicrofluidics       Date:  2011-06-29       Impact factor: 2.800

2.  Controlled embryoid body formation via surface modification and avidin-biotin cross-linking.

Authors:  David Gothard; Scott J Roberts; Kevin M Shakesheff; Lee D Buttery
Journal:  Cytotechnology       Date:  2010-02-10       Impact factor: 2.058

3.  Modeling the inhibition of breast cancer growth by GM-CSF.

Authors:  Barbara Szomolay; Tim D Eubank; Ryan D Roberts; Clay B Marsh; Avner Friedman
Journal:  J Theor Biol       Date:  2012-03-28       Impact factor: 2.691

4.  Hypoxia inducible factors-mediated inhibition of cancer by GM-CSF: a mathematical model.

Authors:  Duan Chen; Julie M Roda; Clay B Marsh; Timothy D Eubank; Avner Friedman
Journal:  Bull Math Biol       Date:  2012-10-17       Impact factor: 1.758

Review 5.  Bioreactor development for stem cell expansion and controlled differentiation.

Authors:  James A King; William M Miller
Journal:  Curr Opin Chem Biol       Date:  2007-07-25       Impact factor: 8.822

Review 6.  Bioprinting for stem cell research.

Authors:  Savas Tasoglu; Utkan Demirci
Journal:  Trends Biotechnol       Date:  2012-12-19       Impact factor: 19.536

7.  Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions.

Authors:  Ying Wang; Bin-Kuan Chou; Sarah Dowey; Chaoxia He; Sharon Gerecht; Linzhao Cheng
Journal:  Stem Cell Res       Date:  2013-08-09       Impact factor: 2.020

8.  Integrating human stem cell expansion and neuronal differentiation in bioreactors.

Authors:  Margarida Serra; Catarina Brito; Eunice M Costa; Marcos F Q Sousa; Paula M Alves
Journal:  BMC Biotechnol       Date:  2009-09-22       Impact factor: 2.563

9.  Single unpurified breast tumor-initiating cells from multiple mouse models efficiently elicit tumors in immune-competent hosts.

Authors:  Natasza A Kurpios; Adele Girgis-Gabardo; Robin M Hallett; Stephen Rogers; David W Gludish; Lisa Kockeritz; James Woodgett; Robert Cardiff; John A Hassell
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

10.  A bioreactor model of mouse tumor progression.

Authors:  George A Thouas; John Sheridan; Kerry Hourigan
Journal:  J Biomed Biotechnol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.